UMB Bank’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5K | Buy |
427
+24
| +6% | +$756 | ﹤0.01% | 1500 |
|
|
2025
Q1 | $13.2K | Buy |
403
+15
| +4% | +$491 | ﹤0.01% | 1454 |
|
|
2024
Q4 | $14K | Hold |
388
| – | – | ﹤0.01% | 1375 |
|
|
2024
Q3 | $12.1K | Buy |
388
+59
| +18% | +$1.84K | ﹤0.01% | 1412 |
|
|
2024
Q2 | $8.8K | Buy |
329
+17
| +5% | +$455 | ﹤0.01% | 1291 |
|
|
2024
Q1 | $10.6K | Buy |
312
+26
| +9% | +$887 | ﹤0.01% | 1271 |
|
|
2023
Q4 | $8.28K | Sell |
286
-127
| -31% | -$3.68K | ﹤0.01% | 1336 |
|
|
2023
Q3 | $11.4K | Hold |
413
| – | – | ﹤0.01% | 1257 |
|
|
2023
Q2 | $12.4K | Hold |
413
| – | – | ﹤0.01% | 1242 |
|
|
2023
Q1 | $15K | Hold |
413
| – | – | ﹤0.01% | 1174 |
|
|
2022
Q4 | $15K | Sell |
413
-86
| -17% | -$3.12K | ﹤0.01% | 1195 |
|
|
2022
Q3 | $17K | Sell |
499
-519
| -51% | -$17.7K | ﹤0.01% | 1163 |
|
|
2022
Q2 | $30K | Buy |
1,018
+45
| +5% | +$1.33K | ﹤0.01% | 1045 |
|
|
2022
Q1 | $31K | Hold |
973
| – | – | ﹤0.01% | 1103 |
|
|
2021
Q4 | $29K | Buy |
+973
| New | +$29K | ﹤0.01% | 1161 |
|
|
2017
Q2 | – | Sell |
-19,000
| Closed | -$595K | – | 337 |
|
|
2017
Q1 | $595K | Hold |
19,000
| – | – | 0.02% | 225 |
|
|
2016
Q4 | $480K | Hold |
19,000
| – | – | 0.02% | 234 |
|
|
2016
Q3 | $470K | Hold |
19,000
| – | – | 0.02% | 246 |
|
|
2016
Q2 | $387K | Hold |
19,000
| – | – | 0.02% | 258 |
|
|
2016
Q1 | $290K | Buy |
19,000
+2,200
| +13% | +$33.6K | 0.01% | 291 |
|
|
2015
Q4 | $226K | Buy |
+16,800
| New | +$226K | 0.01% | 323 |
|